Expertise in
3
conditions

Rafal Tarnawski

Gliwice Branch, 
Gliwice, SL, PL 
Expertise in
3
conditions
Gliwice Branch, 
Gliwice, SL, PL 

Overview

Rafal Tarnawski practices practicing medicine in Gliwice, Poland.

Mr. Tarnawski is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Meningioma, Glioma, Gliomatosis Cerebri, Ependymoma, and Rhizotomy.

He is actively involved in clinical research, co-authoring 39 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Gliwice Branch, Gliwice, SL, Poland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 1/2, Open-Label, Multiple Ascending Dose Trial to Investigate the Safety, Tolerability, Pharmacokinetics, Biological, and Clinical Activity of AGEN2034 in Subjects With Metastatic or Locally Advanced Solid Tumors, With Expansion to Second Line Cervical Cancer
A Phase 1/2, Open-Label, Multiple Ascending Dose Trial to Investigate the Safety, Tolerability, Pharmacokinetics, Biological, and Clinical Activity of AGEN2034 in Subjects With Metastatic or Locally Advanced Solid Tumors, With Expansion to Second Line Cervical Cancer
Enrollment Status: Completed
Publish Date: July 30, 2025
Intervention Type: Drug
Study Drug: AGEN-2034 PD-1 Antibody
Study Phase: Phase 1/Phase 2

39 Total Publications

Corrigendum to "Clinical outcomes of pelvic bone marrow sparing radiotherapy for cervical cancer: A systematic review and meta-analysis of randomised controlled trials". [Clin. Translat. Radiat. Oncol. 47 (2024) 100801].
Corrigendum to "Clinical outcomes of pelvic bone marrow sparing radiotherapy for cervical cancer: A systematic review and meta-analysis of randomised controlled trials". [Clin. Translat. Radiat. Oncol. 47 (2024) 100801].
Journal: Clinical and translational radiation oncology
Published: January 15, 2026

Frequently Asked Questions about Rafal Tarnawski

Is Rafal Tarnawski a top-rated expert for Meningioma?

MediFind is an objective health platform that identifies experts based on real-world data. Rafal Tarnawski is classified as an Advanced expert for Meningioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Rafal Tarnawski participate in research or clinical trials?

Yes. Rafal Tarnawski has published 39 articles and abstracts on conditions like Meningioma. You can view a list of Rafal Tarnawski's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Tarnawski's expertise for a condition
ConditionClose
      View All 11 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile